Reyon Pharmaceutical
이연제약KRX: 102460· Fiscal year 2025· reyonpharm.co.kr ↗
Average salary
$57.3K
₩76.4M
▼ 11.9% vs 2024
Employees
457
▲ 1.8% vs 2024
Average tenure
Not disclosed
Estimated take-home of this pay:$3.9K / monthCalculate →
Workplace
Women's pay (men = 100)55
Women among staff32.4%
Contract staff1.1%
Recent official filings
- 2026-11-13Quarterly report (2026.09)
- 2026-10-28MajorShare issuance result
- 2026-10-16MajorShare issuance result
- 2026-08-14Half-year report (2026.06)
Quick read
- Average pay is 25% above the median of the companies we track.
- Average pay fell 11.9% from 2024.
- Headcount grew by 8 (1.8%) from 2024.
- Ranks #32 of 238 Healthcare & Pharma companies in this country by pay.
- Revenue fell 1.6% year over year.
- Revenue has shrunk two years in a row.
- Operating loss of $22.7M in 2025.
Last 3 years
Revenue
Operating income
See the share price on Naver Finance ↗
Investor metrics
2025
- Revenue per employee
- $239.1K
- Net profit per employee
- -$48.6K
- Operating margin
- -20.7%
- Net margin
- -20.3%
- ROE
- -13.5%
- Debt-to-equity
- 111.1%
- Equity ratio
- 47.4%
Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.